pillbase.ru

Anzupgo

Active substance: delgocitinib

CREAM · DELGOCITINIB 20 mg/g

United StatesActive

Marketing holder: LEO Pharma, Inc

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
EU 1
  • Anzupgo
    Delgocitinib
    EMEA/H/C/006109
    LEO Pharma A/S
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208f-caa8-70f5-9c6a-4ce555db3de5;count=1 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
50222-280
Registration status
Active
Dispensing
Prescription only
Route
TOPICAL
Sources
  • product · openFDA NDC · 50222-280 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 50222-280 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 50222-280 · Verified 2026-10-09 · open in source